SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-045445
Filing Date
2023-12-19
Accepted
2023-12-19 17:10:11
Documents
12
Period of Report
2023-12-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46714
  Complete submission text file 0001493152-23-045445.txt   222076

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE shph-20231218.xsd EX-101.SCH 3030
3 XBRL LABEL FILE shph-20231218_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE shph-20231218_pre.xml EX-101.PRE 22369
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3433
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41488 | Film No.: 231498382
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)